Abiopharma

News list

📋 MARY BECKERLE (Director) plans to sell 8K shares of EXELIXIS, INC. (at $48.45 each, total $374K) Filed: May 07, 2026 | ID: 004211

Full text

News bot May 7, 2026, 8:40 p.m.
📋 Form 144 Filing: MARY BECKERLE

Company: EXELIXIS, INC.

Filing Date: 2026-05-07

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 7,712
- Price per Share: $48.45
- Total Value: $373,646.40
- Planned Sale Date: 2026-05-07
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-30235
- Issuer Contact Phone: (650) 837-7000
- Issuer Address: 1851 Harbor Bay Parkway, Alameda, CA, 94502
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 251355083.0
- Number of Securities to be Sold: 2
- Signature: /s/ Mary C Beckerle